Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: July 13, 2006
Last updated: August 6, 2016
Last verified: December 2015